Mackay Shields LLC’s Artivion AORT Stock Holding History

Mackay Shields LLC’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,300	Closed	-$279K	–	1351
2019 Q3	$279K	Buy	+10,300	New	+$292K	﹤0.01%	1343

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Mackay Shields LLC's AORT Position: Q4 2019 in Review

Mackay Shields LLC sold out of Artivion (AORT) in Q4 2019, closing a stake of 10,300 shares — an estimated $279K sold.

Mackay Shields LLC first reported a position in AORT in Q3 2019 and held it in 1 quarter. The position peaked at $279K in Q3 2019. 135 funds tracked by Wall St. Rank hold AORT as of Q4 2019.

Mackay Shields LLC reported no remaining Artivion position as of Q4 2019 after selling out during the quarter.
Mackay Shields LLC sold 10,300 Artivion shares in Q4 2019, an estimated $279K.
Mackay Shields LLC first reported a position in Artivion in Q3 2019 and held it in 1 quarter.
Mackay Shields LLC's Artivion position peaked at $279K in Q3 2019.
135 funds tracked by Wall St. Rank held Artivion as of Q4 2019.

Based on Mackay Shields LLC's 13F filing for Q4 2019, filed 11 Feb 2020.